Sunday, 23 August 2026European Markets
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Work with this data → vianewsagency.com

ONWARD MEDICAL Stock Bullish Momentum With A 12% Jump So Far Today

Loading stream...

(VIANEWS) - Shares of ONWARD MEDICAL (BEL 20: ONWD.BR) rose by a staggering 12.73% to €5.58 at 11:23 EST on Thursday, following the last session's downward trend. BEL 20 is dropping 0.38% to €3,642.53, after three consecutive sessions in a row of losses. This seems, up until now, a somewhat down trend trading session today.

ONWARD MEDICAL's last close was €4.88, 40.7% below its 52-week high of €8.23.

About ONWARD MEDICAL

Onward Medical N.V., a medical technology company, focuses on developing therapies for spinal cord injuries in the Netherlands and internationally. The company engages in developing ARC-EX, an external non-invasive platform that consists of a wearable stimulator and wireless programmer; and ARCIM, an implantable platform, which consists of an implantable pulse generator and lead that is placed near the spinal cord. It also engages in developing Up-LIFT Trial to evaluate the safety and effectiveness of non-invasive electrical spinal cord stimulation to treat upper extremity functional deficits with chronic tetraplegia. The company was founded in 2014 and is headquartered in Eindhoven, Netherlands.

Earnings Per Share

As for profitability, ONWARD MEDICAL has a trailing twelve months EPS of €-1.1.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -48.44%.

Moving Average

ONWARD MEDICAL's value is way above its 50-day moving average of €4.83 and higher than its 200-day moving average of €5.53.

Volume

Today's last reported volume for ONWARD MEDICAL is 50765 which is 694.56% above its average volume of 6389.

Revenue Growth

Year-on-year quarterly revenue growth grew by 45.8%, now sitting on 2.15M for the twelve trailing months.

Volatility

ONWARD MEDICAL's last week, last month's, and last quarter's current intraday variation average was 1.28%, 0.09%, and 2.12%.

ONWARD MEDICAL's highest amplitude of average volatility was 2.51% (last week), 1.46% (last month), and 2.12% (last quarter).

More news about ONWARD MEDICAL (ONWD.BR).